Development and Psychometric Properties of the Inflammatory Bowel Disease Distress Scale (IBD-DS): A New Tool to Measure Disease-Specific Distress

Inflammatory Bowel Diseases

Volumn 24, Issue 9, 2018, Pages 2068-2077

  Dibley, Lesley ^a,b   Czuber Dochan, Wladyslawa ^c   Woodward, Sue ^c   Wade, Tiffany ^c   Bassett, Paul ^d   Sturt, Jackie ^c   Norton, Christine ^c  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d Amersham   (United Kingdom)

Author keywords

assessment; distress; inflammatory bowel disease

Indexed keywords

ADOLESCENT; ADULT; AGED; DIAGNOSIS; DISTRESS SYNDROME; ETIOLOGY; FACTOR ANALYSIS; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; MALE; MENTAL STRESS; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; QUESTIONNAIRE; REPRODUCIBILITY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL DISTRESS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85054903241     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1093/ibd/izy108     Document Type: Article

References (67)

1. Dudley-Brown S. Prevention of psychological distress in persons with inflammatory bowel disease. Issues Ment Health Nurs. 2002;23:403-422.
2. Farrell D, McCarthy G, Savage E. Self-reported symptom burden in individuals with inflammatory bowel disease. J Crohns Colitis. 2016;10:315-322.
3. Pandit AU, Bailey SC, Curtis LM, et al. Disease-related distress, self-care and clinical outcomes among low-income patients with diabetes. J Epidemiol Community Health. 2014;68:557-564.
4. Ridner S. Psychological distress: A concept analysis. J Adv Nurs. 2004;45:536-545.
5. Dennick K, Sturt J, Hessler D, et al. High rates of elevated diabetes distress in research populations: A systmatic review and meta-analysis. Int Diabetes Nursing. 2016;12:93-107.
6. Dennick K, Sturt J, Speight J. What is diabetes distress and how can we measure it A narrative review and conceptual model. J Diabetes Complications. 2017;31:898-911.
7. Sturt J, Dennick K, Due-Christensen M, McCarthy K. The detection and management of diabetes distress in people with type 1 diabetes. Curr Diab Rep. 2015;15:101.
8. Sturt J, Dennick K, Hessler D, et al. Effective interventions for reducing diabetes distress: systematic review and meta-analysis. Int Diabetes Nursing. 2015;12:40-55.
9. Hagger V, Hendrieckx C, Sturt J, et al. Diabetes distress among adolescents with type 1 diabetes: A systematic review. Curr Diab Rep. 2016;16:9.
10. Oraka E, King ME, Callahan DB. Asthma and serious psychological distress: prevalence and risk factors among US adults, 2001-2007. Chest. 2010;137:609-616.
11. Hyland ME, Ley A, Fisher DW, et al. Measurement of psychological distress in asthma and asthma management programmes. Br J Clin Psychol. 1995;34(Pt 4):601-611.
12. Boman K, Lindahl A, Bjork O. Disease-related distress in parents of children with cancer at various stages after the time of diagnosis. Acta Oncol. 2003;42:137-146.
13. Haun MW, Sklenarova H, Villalobos M, et al. Depression, anxiety and disease-related distress in couples affected by advanced lung cancer. Lung Cancer. 2014;86:274-280.
14. Schnoll RA, Harlow LL. Using disease-related and demographic variables to form cancer-distress risk groups. J Behav Med. 2001;24:57-74.
15. Janssens AC, van Doorn PA, de Boer JB, et al. Perception of prognostic risk in patients with multiple sclerosis: The relationship with anxiety, depression, and disease-related distress. J Clin Epidemiol. 2004;57:180-186.
16. Woodward S, Dibley L, Coombes S, et al. Identifying disease-specific distress in patients with inflammatory bowel disease. Br J Nurs. 2016;25:649-660.
17. Graff LA, Walker JR, Clara I, et al. Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls. Am J Gastroenterol. 2009;104:2959-2969.
18. Hyphantis TN, Tomenson B, Bai M, et al. Psychological distress, somatization, and defense mechanisms associated with quality of life in inflammatory bowel disease patients. Dig Dis Sci. 2010;55:724-732.
19. Fisher L, Skaff MM, Mullan JT, et al. Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics. Diabetes Care. 2007;30:542-548.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
21. Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: A call for greater clarity and precision. Diabet Med. 2014;31:764-772.
22. Sturt J, McCarthy K, Dennick K, et al. What characterises diabetes distress and its resolution A documentary analysis. Int Diabetes Nursing. 2015;12:56-62.
23. Fisher L, Glasgow RE, Mullan JT, et al. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008;6:246-252.
24. Fisher L, Hessler DM, Polonsky WH, et al. When is diabetes distress clinically meaningful?: establishing cut points for the diabetes distress scale. Diabetes Care. 2012;35:259-264.
25. Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18:754-760.
26. Selinger CP, Robinson A, Leong RW. Clinical impact and drivers of non-adherence to maintenance medication for inflammatory bowel disease. Expert Opin Drug Saf. 2011;10:863-870.
27. Jackson CA, Clatworthy J, Robinson A, Horne R. Factors associated with non-adherence to oral medication for inflammatory bowel disease: A systematic review. Am J Gastroenterol. 2010;105:525-539.
28. Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management. Inflamm Bowel Dis. 2009;15:1105-1118.
29. Nahon S, Lahmek P, Durance C, et al. Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2086-2091.
30. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: A literature review. Inflamm Bowel Dis. 2007;13:225-234.
31. Czuber-Dochan W, Dibley LB, Terry H, et al. The experience of fatigue in people with inflammatory bowel disease: An exploratory study. J Adv Nurs. 2013;69:1987-1999.
32. Dibley L, Norton C, Cotterill N, et al. Development and initial validation of a disease-specific bowel continence questionnaire for inflammatory bowel disease patients: The ICIQ-IBD. Eur J Gastroenterol Hepatol. 2016;28:233-239.
33. Dibley L, Norton C. Experiences of fecal incontinence in people with inflammatory bowel disease: self-reported experiences among a community sample. Inflamm Bowel Dis. 2013;19:1450-1462.
34. Dibley L, Norton C, Whitehead E. The experience of stigma in inflammatory bowel disease: An interpretive (hermeneutic) phenomenological study. J Adv Nurs. 2018;74:838-851.
35. Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes: development of the Diabetes Distress Scale. Diabetes Care. 2005;28:626-631.
36. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361-370.
37. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34-42.
38. Rothrock NE, Kaiser KA, Cella D. Developing a valid patient-reported outcome measure. Clin Pharmacol Ther. 2011;90:737-742.
39. Cotterill N, Norton C, Avery KN, et al. Psychometric evaluation of a new patient-completed questionnaire for evaluating anal incontinence symptoms and impact on quality of life: The ICIQ-B. Dis Colon Rectum. 2011;54:1235-1250.
40. Center for Drug Evaluation and Research. Guidance for Industry. Patient Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Silver Spring, MD: US Department of Health; 2009.
41. Czuber-Dochan W, Norton C, Bassett P, et al. Development and psychometric testing of Inflammatory Bowel Disease Fatigue (IBD-F) patient self-assessment scale. J Crohns Colitis. 2014;8:1398-1406.
42. Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31:180-191.
43. Anthoine E, Moret L, Regnault A, et al. Sample size used to validate a scale: A review of publications on newly-developed patient reported outcomes measures. Health Qual Life Outcomes. 2014;12:176.
44. Morgado F, Meireles J, Neves C, et al. Scale development: Ten main limitations and recommendations to improve future research practices. Psicol Refl Crit. 2018;30:3.
45. Harvey R, Bradshaw J. A simple index of Crohn's disease activity. Lancet. 1980;1:514.
46. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A Simple Clinical Colitis Activity Index. Gut. 1998;43:29-32.
47. Staniszewska S, Haywood KL, Brett J, et al. Patient and public involvement in patient-reported outcome measures: evolution not revolution. Patient. 2012;5:79-87.
48. Price A, Albarqouni L, Kirkpatrick J, et al. Patient and public involvement in the design of clinical trials: An overview of systematic reviews. J Eval Clin Pract. 2018;24:240-253.
49. Garcia AA. Cognitive interviews to test and refine questionnaires. Public Health Nurs. 2011;28:444-450.
50. Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009;18:1263-1278.
51. Rosland AM, Heisler M, Choi HJ, et al. Family influences on self-management among functionally independent adults with diabetes or heart failure: do family members hinder as much as they help Chronic Illn. 2010;6:22-33.
52. Irvine EJ. Development and subsequent refinement of the Inflammatory Bowel Disease Questionnaire: A quality-of-life instrument for adult patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1999;28:S23-S27.
53. Bodger K, Ormerod C, Shackcloth D, et al; IBD Control Collaborative. Development and validation of a rapid, generic measure of disease control from the patient's perspective: The IBD-control questionnaire. Gut. 2014;63:1092-1102.
54. Weldring T, Smith SM. Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Serv Insights. 2013;6:61-68.
55. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27:S217-S232.
56. Assari S, Lankarani MM, Montazeri A, et al. Are generic and disease-specific health related quality of life correlated The case of chronic lung disease due to sulfur mustard. J Res Med Sci. 2009;14:285-290.
57. Casati J, Toner BB, de Rooy EC, et al. Concerns of patients with inflammatory bowel disease: A review of emerging themes. Dig Dis Sci. 2000;45:26-31.
58. Drossman DA, Patrick DL, Mitchell CM, et al. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379-1386.
59. Jelsness-Jorgensen LP, Moum B, Bernklev T. Worries and concerns among inflammatory bowel disease patients followed prospectively over one year. Gastroenterol Res Pract. 2011;2011:492034.
60. Lonnfors S, Vermeire S, Greco M, et al. IBD and health-related quality of life-discovering the true impact. J Crohns Colitis. 2014;8:1281-1286.
61. Gregoire C, Bragard I, Jerusalem G, et al. Group interventions to reduce emotional distress and fatigue in breast cancer patients: A 9-month follow-up pragmatic trial. Br J Cancer. 2017;117:1442-1449.
62. Holtmaat K, van der Spek N, Witte BI, et al. Moderators of the effects of meaning-centered group psychotherapy in cancer survivors on personal meaning, psychological well-being, and distress. Support Care Cancer. 2017;25:3385-3393.
63. van Son J, Nyklicek I, Pop VJ, et al. The effects of a mindfulness-based intervention on emotional distress, quality of life, and HBA(1c) in outpatients with diabetes (DiaMind): A randomized controlled trial. Diabetes Care. 2013;36:823-830.
64. Zoffmann V, Vistisen D, Due-Christensen M. Flexible guided self-determination intervention for younger adults with poorly controlled type 1 diabetes, decreased hba1c and psychosocial distress in women but not in men: A real-life RCT. Diabet Med. 2015;32:1239-1246.
65. Mussell M, Bocker U, Nagel N, et al. Reducing psychological distress in patients with inflammatory bowel disease by cognitive-behavioural treatment: exploratory study of effectiveness. Scand J Gastroenterol. 2003;38:755-762.
66. Sajadinejad MS, Asgari K, Molavi H, et al. Psychological issues in inflammatory bowel disease: An overview. Gastroenterol Res Pract. 2012;2012:106502.
67. Colombel J-F, Keir ME, Schurl A, et al. Discrepancies between patient-reported outcomes and endoscopic and histological appearance in UC. Gut. 2017;66:2063-2068.